Pharmaceutical Localization Is Drawing Fresh Capital

Several new projects aimed at localising the production of domestic medicines have moved forward this year as part of the broader non-resource investment push, alongside smaller allocations tied to healthcare within sovereign investment vehicles. This remains an early-stage opportunity worth tracking as specific manufacturing partners and equipment suppliers are identified.